Description

Description

Amodip-V Plus 5/160/12.5mg is a triple-combination tablet manufactured by Mass Pharma, bringing together three active ingredients, Amlodipine, Valsartan, and Hydrochlorothiazide, in a single once-daily dose. This formulation is typically intended for patients with more persistent or difficult-to-control hypertension, where dual-combination therapies have not been sufficient to achieve target blood pressure levels. Each of the three ingredients works through a different mechanism: Amlodipine, a calcium channel blocker, relaxes blood vessel walls to ease blood flow; Valsartan, an angiotensin receptor blocker, prevents a hormone from causing blood vessels to narrow; and Hydrochlorothiazide, a thiazide diuretic, helps the kidneys eliminate excess salt and water, reducing overall fluid volume in the bloodstream. By addressing blood pressure from three complementary angles within one tablet, Amodip-V Plus aims to provide more thorough control while keeping the treatment regimen straightforward. Each pack contains 14 tablets, meant for long-term use as directed by a treating physician.

Ingredients

Each Amodip-V Plus tablet contains three active pharmaceutical ingredients: Amlodipine at 5mg, Valsartan at 160mg, and Hydrochlorothiazide at 12.5mg. The tablet also includes standard inactive excipients such as fillers, binding agents, and a film-coating layer, which support the tablet’s stability and ease of swallowing without contributing to its therapeutic activity.

Dosage Form

Amodip-V Plus is presented as a film-coated oral tablet, combining 5mg of Amlodipine, 160mg of Valsartan, and 12.5mg of Hydrochlorothiazide in each unit. The tablets are supplied in blister packaging, with 14 tablets included per pack, intended for oral use only.

Uses

Amodip-V Plus is primarily prescribed for the management of hypertension in patients who require a triple-combination approach to achieve adequate blood pressure control, typically after dual therapies involving two of these ingredients have proven insufficient. By combining a calcium channel blocker, an angiotensin receptor blocker, and a diuretic in one tablet, this medicine offers a comprehensive strategy for lowering blood pressure and reducing the long-term risks linked to sustained hypertension, including stroke, heart attack, and kidney damage. It is generally used as part of a broader treatment plan that also incorporates lifestyle and dietary adjustments recommended by a healthcare provider.

How to Use

Amodip-V Plus should only be taken as prescribed by a physician familiar with the patient’s full treatment history. It is usually taken once daily, at a consistent time, with or without food, though taking it earlier in the day may help reduce nighttime urination caused by its diuretic component. The tablet should be swallowed whole with a sufficient amount of water and should not be crushed, split, or chewed unless specifically advised otherwise by a doctor or pharmacist. Because this is a triple-combination medicine intended for long-term use, doses should not be skipped, and treatment should never be stopped abruptly without medical consultation, even if blood pressure appears well controlled. If a dose is missed, it should be taken as soon as remembered, unless the next dose is nearly due, in which case the missed dose should simply be skipped.

Side Effects

Given that Amodip-V Plus combines three active ingredients, patients may experience a wider range of possible side effects, though not everyone will be affected and severity varies by individual. Commonly reported effects include dizziness, headache, fatigue, increased urination, and swelling of the ankles or feet. Some patients may experience symptoms of low blood pressure, such as lightheadedness when standing, particularly during the initial period of treatment or after a dose adjustment. Less frequently, effects such as muscle cramps, nausea, or disturbances in blood electrolyte levels, including low potassium or sodium and elevated potassium in some cases, may occur due to the combined action of Valsartan and Hydrochlorothiazide. In rare instances, more serious reactions such as severe allergic responses, marked drops in blood pressure, irregular heart rhythm, or signs of kidney function changes may develop, requiring immediate medical attention. Regular monitoring through blood tests is often advised to track electrolyte and kidney function throughout treatment. Any unusual or worsening symptoms should be reported to a healthcare provider promptly.

Pregnancy & Breastfeeding

Amodip-V Plus should not be used during pregnancy without explicit medical guidance, as both Valsartan and Hydrochlorothiazide are generally not recommended during pregnancy due to potential risks to fetal development, particularly beyond the first trimester. Breastfeeding mothers should also consult their doctor before starting this medication, since all three active ingredients may pass into breast milk, and the combined safety profile during lactation requires individual assessment. Anyone who becomes pregnant while on this treatment should notify their doctor immediately so the treatment plan can be reviewed.

Storage Instructions

Amodip-V Plus tablets should be stored in a cool, dry place, protected from direct sunlight and excess moisture. It is recommended to keep the tablets in their original blister packaging until they are ready to be used, and to store them securely out of the reach of children and pets. Tablets should not be used after the expiry date printed on the pack.

FAQs

Why does this tablet contain three different medicines?
Combining Amlodipine, Valsartan, and Hydrochlorothiazide allows each ingredient to address blood pressure through a distinct mechanism, which can be more effective for patients whose hypertension has not responded well to one or two medicines alone.

Who is typically prescribed this triple-combination tablet?
It is generally reserved for patients with more resistant hypertension who have already tried dual-combination therapy without achieving their target blood pressure levels.

Is more frequent monitoring needed with this medication?
Yes, because it combines three active ingredients, doctors often recommend regular checks of blood pressure, kidney function, and electrolyte levels to ensure the treatment remains safe and effective.

Can I take other blood pressure medicines alongside Amodip-V Plus?
This should only be done under close medical supervision, as adding further antihypertensive agents can increase the risk of excessively low blood pressure or electrolyte imbalance.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.